North Star Investment Management Corp. - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 24 filers reported holding MOLECULIN BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q3 2023$107
-26.2%
2500.0%0.00%
Q2 2023$145
-39.6%
2500.0%0.00%
Q1 2023$240
-9.4%
2500.0%0.00%
Q4 2022$2652500.0%0.00%
Q3 2022$02500.0%0.00%
Q2 2022$02500.0%0.00%
Q1 2022$02500.0%0.00%
Q4 2021$0
-100.0%
2500.0%0.00%
Q3 2021$1,0000.0%2500.0%0.00%
Q2 2021$1,0000.0%2500.0%0.00%
Q1 2021$1,0002500.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,040,529$1,852,0000.61%
Sigma Planning Corp 57,500$102,0000.00%
OSAIC HOLDINGS, INC. 4,233$7,0000.00%
BANK OF AMERICA CORP /DE/ 6,650$12,0000.00%
WELLS FARGO & COMPANY/MN 4,176$7,0000.00%
NORTHERN TRUST CORP 50,731$90,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 245,612$437,0000.00%
STATE STREET CORP 71,397$127,0000.00%
North Star Investment Management Corp. 250$00.00%
View complete list of MOLECULIN BIOTECH INC shareholders